MARKET RADAR
SENSEX     NIFTY      Refresh
Marksans Pharma Balance Sheet, Marksans Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Balance Sheet - Marksans Pharma
Marksans Pharma
BSE: 524404|NSE: MARKSANS|ISIN: INE750C01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 17:00
3.93
0.18 (4.8%)
VOLUME 169,013
LIVE
NSE
May 24, 17:00
3.85
0.15 (4.05%)
VOLUME 21,019
Download Annual Report PDF Format 2012 | 2011 | 2010
Previous Years »

Balance Sheet of Marksans Pharma

 ------------------- in Rs. Cr. -------------------
Mar '12 Mar '11 Mar '10 Mar '09 Mar '08
12 mths 12 mths 12 mths 12 mths 12 mths
Sources Of Funds
Total Share Capital 50.28 50.28 50.28 50.28 49.44
Equity Share Capital 36.78 36.78 36.78 36.78 35.94
Share Application Money 1.16 0.00 0.00 0.00 0.00
Preference Share Capital 13.50 13.50 13.50 13.50 13.50
Reserves -239.52 -92.42 125.37 108.82 92.04
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Networth -188.08 -42.14 175.65 159.10 141.48
Secured Loans 92.38 111.76 175.94 117.87 103.26
Unsecured Loans 0.00 290.09 176.96 201.19 199.85
Total Debt 92.38 401.85 352.90 319.06 303.11
Total Liabilities -95.70 359.71 528.55 478.16 444.59
Mar '12 Mar '11 Mar '10 Mar '09 Mar '08
12 mths 12 mths 12 mths 12 mths 12 mths
Application Of Funds
Gross Block 122.77 213.12 359.82 335.21 252.09
Less: Accum. Depreciation 46.11 28.22 65.68 56.25 47.03
Net Block 76.66 184.90 294.14 278.96 205.06
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00
Investments 23.51 67.62 77.62 67.56 2.70
Inventories 40.25 40.01 83.06 98.33 123.71
Sundry Debtors 74.19 72.17 67.20 50.82 52.85
Cash and Bank Balance 17.58 1.55 9.12 0.56 42.99
Total Current Assets 132.02 113.73 159.38 149.71 219.55
Loans and Advances 13.73 32.96 22.87 19.37 75.32
Fixed Deposits 0.00 24.69 23.39 12.44 0.21
Total CA, Loans & Advances 145.75 171.38 205.64 181.52 295.08
Deffered Credit 0.00 0.00 0.00 0.00 0.00
Current Liabilities 336.50 64.21 48.98 50.10 58.21
Provisions 5.12 0.00 0.09 0.27 1.12
Total CL & Provisions 341.62 64.21 49.07 50.37 59.33
Net Current Assets -195.87 107.17 156.57 131.15 235.75
Miscellaneous Expenses 0.00 0.01 0.21 0.48 1.08
Total Assets -95.70 359.70 528.54 478.15 444.59
Contingent Liabilities 2.05 0.19 2.50 0.86 0.00
Book Value (Rs) -5.51 -1.51 4.41 3.96 3.56
Source : Dion Global Solutions Limited

Results of Marksans Pharma

  • News
  • Results
  • Estimates
  • Analysis

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
Quick Links for marksanspharma
Related Searches marksanspharma Stock Price, Marksans%20Pharma Stock Quote, Marksans%20Pharma Results , Marksans%20Pharma News .. More »
Follow moneycontrol.com

Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News | Markets | IPO | Technicals | Mutual Fund | Commodities | Best Portfolio Manager | Bse Sensex | Bombay Stock Exchange | Share Market Live | Recession 2011 | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | National Stock Exchange | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Property rates in India | Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |  Intuit Money Manager | RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget  | Financial Glossary  |  Message Board | Moneybhai | India's Premiere Technology Guide |  History India | Davos  | Tata Steel | Wockhardt | Etihad Airways | Mamata Banerjee | Natural gas | Indian rupee | Bank | SpiceJet | Manmohan Singh | Mobile app
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.